DIANA TOMLIANOVICH: Open Payments
NPI 1497288492 · MOUNT VERNON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 67 payments from 16 companies in 2025. Trend: 2023 $501 · 2024 $1,098 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $317 |
| Teva Pharmaceuticals USA, Inc. | 11 | $277 |
| Alkermes, Inc. | 12 | $187 |
| E.R. Squibb & Sons, L.L.C. | 4 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 2 | $122 |
| Supernus Pharmaceuticals, Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 1 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
Products named: VRAYLAR, ARISTADA, UZEDY, COBENFY, REXULTI, CAPLYTA, AUSTEDO XR, Qelbree.
Industry payments across IL — which companies pay providers there.
